- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01917292
Impact of Periodontal Intervention on Vascular Dysfunction
Periodontal Intervention Improves Vascular Function Among Chinese Prehypertensive Adults With Periodontitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Periodontitis is one of the low-grade chronic diseases, and it is the principal cause of tooth loss among middle-aged and elderly. Recently, epidemiological data indicate that patients with periodontitis are associated with increases in blood pressure levels and hypertension prevalence. Furthermore, studies from cross-sectional investigations demonstrate that hypertensive patients with periodontitis may enhance the risk and degree of vascular damage. Therefore, periodontal therapy is a novel therapeutic strategy to prevent the occurrence of BP elevation and retard the development vascular injury.
The term "prehypertension" indicates those with BPs ranging from 120 to 139 mm Hg systolic and/or 80 to 89 mm Hg diastolic blood pressure. Accumulating evidence suggests that subjects with prehypertension is associated with higher incidence of atherosclerotic vascular disease. However, until now there are no available data to investigate the influence of periodontitis on prehypertension and whether periodontal intervention may reduce the BP rise in subjects with prehypertension and improve the vascular function. We hypothesized that periodontitis leads to elevation in BP and periodontal therapy improves vascular function in subjects with prehypertension. To address these assumptions, The present study is designed to study the effect of periodontal intervention on blood pressure and vascular function and inflammatory biomarkers among Chinese prehypertensive adults with moderate to severe periodontal disease, and determine whether intensive periodontal therapy improves these measures over a 6-month follow-up period.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- The First Affiliated Hospital, Sun Yat-sen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects must be 18 years of age or older
- Moderate to severe generalized periodontitis(probing pocket depths of >6 mm and Marginal alveolar bone loss of >30%) with 50% or more of their teeth affected
- Have at least 16 natural teeth excluding third molars
- BPs ranging from 120 to 139 mm Hg systolic and/or 80 to 89 mm Hg diastolic blood pressure
- Provide informed consent and willingness to cooperate with the study protocol
Exclusion Criteria:
- History of antibiotic use in the previous three months
- Pregnant or lactating females
- Systemic diseases such as diabetes, HIV/AIDS, liver disease, chronic renal failure, tuberculosis, and autoimmune diseases
- Medical history of cardiovascular disease: Acute myocardial infarct, stable angina, unstable angina, heart failure, atrial fibrillation, atrioventricular blockade, peripheral vascular disease, cerebrovascular accident, hypertension
- Patients who received periodontal treatment within the last 6 months
- Patients who require antibiotic prophylaxis before examination or treatment
- Patients with mental retardation and dementia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Periodontal care
|
|
|
Experimental: One-Stage Full-Mouth Disinfection
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline in the Number of Endothelial Microparticle at 6 months
Time Frame: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
Change from Baseline in the Blood Pressure at 6 months
Time Frame: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Brachia-ankle Pulse Wave Velocity(baPWV)
Time Frame: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
|
Changes in high-sensitivity C-Reactive Protein(hs-CRP) and Interleukin-6(IL-6)
Time Frame: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Compare the changes of traditional inflammatory biomarkers:hs-CRP and IL-6 over a 6-month follow-up period.
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
Expression of the Long non-protein-coding RNA(lncRNA) and microRNA
Time Frame: baseline
|
baseline
|
|
|
Changes in Malondialdehyde(MDA) and Superoxide Dismutase(SOD)
Time Frame: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
|
Change in Periodontal Inflamed Surface Area(PISA)
Time Frame: Baseline; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Bleeding on probing(BOP), clinical attachment loss (CAL) and gingival recession(GR) are measured to calculate the PISA.The PISA reflects the surface area of bleeding pocket epithelium in square millimetres.
|
Baseline; 3 months post periodontal therapy; 6 months post periodontal therapy
|
|
Change in Endothelium-dependent Brachial Artery Flow-mediated Dilation(FMD)
Time Frame: Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Baseline; 1 month post periodontal therapy; 3 months post periodontal therapy; 6 months post periodontal therapy
|
Collaborators and Investigators
Investigators
- Study Director: Jun Ying Yang, Master, First Affiliated Hospital, Sun Yat-Sen University
- Study Chair: Jun Tao, M.D.,phD., First Affiliated Hospital, Sun Yat-Sen University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20130718emp
- 31270992 (Registry Identifier: National Natural Science Foundation of China)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prehypertension
-
Liaquat University of Medical & Health SciencesUniversity of Rome Tor VergataNot yet recruitingHypertension | PrehypertensionItaly
-
University of LjubljanaRecruitingHealthy | Prehypertension (Elevated Blood Pressure) or HypertensionSlovenia
-
Eetho Brands, IncNot yet recruitingPrehypertensionIndia
-
Foundation University IslamabadRecruiting
-
Rockefeller UniversityCompleted
-
LycoRed Ltd.Maccabi Healthcare Services, IsraelCompletedPrehypertensionIsrael
-
Zhiming ZhuCompletedPrehypertensionChina
-
University of HartfordRecruitingPre Hypertension | Hypertension (HTN)United States
-
Vanderbilt UniversityCompleted
-
University of California, San DiegoEnrolling by invitationHypertension | Prehypertension
Clinical Trials on Periodontal care
-
University of LahoreRecruitingPatient CompliancePakistan
-
Universidad Complutense de MadridSociedad Española de Periodoncia (SEPA); Dentaid SLRecruitingPeri-implant MucositisSpain
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingPeriodontitis | GingivitisChina
-
Xu LiuThe Second People's Hospital of Anhui Province; The First People's Hospital...Active, not recruitingPeriodontitis | Atrial FibrillationChina
-
University College, LondonCompletedPeriodontitis | Intimal Medial Thickness of Internal Carotid ArteryUnited Kingdom
-
Postgraduate Institute of Dental Sciences RohtakUnknownPeriodontal Bone LossIndia
-
CAIO VINICIUS GONÇALVES ROMAN TORRESCompletedRheumatoid Arthritis | Periodontitis
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
University Hospital, ToursCompletedPeriodontal DiseasesFrance
-
University of Sao Paulo General HospitalActive, not recruitingSjogren's SyndromeBrazil